Gemcitabine plus nab-paclitaxel until progression or alternating with FOLFIRI.3, as first-line treatment for patients with metastatic pancreatic adenocarcinoma: The Federation Francophone de Cancérologie Digestive-PRODIGE 37 randomised phase II study (FIRGEMAX)

2020 ◽  
Vol 136 ◽  
pp. 25-34
Author(s):  
Yves Rinaldi ◽  
Anne-Laure Pointet ◽  
Faiza Khemissa Akouz ◽  
Karine Le Malicot ◽  
Bidaut Wahiba ◽  
...  

2020 ◽  
Vol 148 (3) ◽  
pp. 682-691
Author(s):  
Eric Assenat ◽  
Laurent Mineur ◽  
Caroline Mollevi ◽  
Evelyne Lopez‐Crapez ◽  
Catherine Lombard‐Bohas ◽  
...  






2003 ◽  
Vol 13 (2) ◽  
pp. 130-137 ◽  
Author(s):  
T. Bauknecht ◽  
A. Hefti ◽  
G. Morack ◽  
C. Villena-Heinsen ◽  
D. Wallwiener ◽  
...  


2010 ◽  
Vol 10 (4) ◽  
pp. 313-317 ◽  
Author(s):  
Juan de la Haba-Rodriguez ◽  
Rosario González Mancha ◽  
Gumersindo Pérez Manga ◽  
Enrique Aranda Aguilar ◽  
José Manuel Baena Cañada ◽  
...  


Lung Cancer ◽  
2003 ◽  
Vol 39 (1) ◽  
pp. 77-84 ◽  
Author(s):  
J.M Vieitez ◽  
M Valladares ◽  
M Gracia ◽  
M Gonzalez-Barón ◽  
G Martı́n ◽  
...  




Sign in / Sign up

Export Citation Format

Share Document